IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,556 | +10.6% | 850 | 0.0% | 0.01% | +16.7% |
| Q2 2023 | $34,876 | +14.8% | 850 | 0.0% | 0.01% | +9.1% |
| Q1 2023 | $30,379 | -5.4% | 850 | 0.0% | 0.01% | -8.3% |
| Q4 2022 | $32,105 | -99.9% | 850 | 0.0% | 0.01% | -25.0% |
| Q3 2022 | $37,596,000 | +19.5% | 850 | 0.0% | 0.02% | +23.1% |
| Q2 2022 | $31,467,000 | -6.5% | 850 | 0.0% | 0.01% | +8.3% |
| Q1 2022 | $33,669,000 | +30.2% | 850 | 0.0% | 0.01% | +33.3% |
| Q4 2021 | $25,866,000 | -15.9% | 850 | -7.3% | 0.01% | -25.0% |
| Q3 2021 | $30,756,000 | -25.4% | 917 | 0.0% | 0.01% | -29.4% |
| Q1 2021 | $41,228,000 | -20.5% | 917 | 0.0% | 0.02% | -32.0% |
| Q4 2020 | $51,847,000 | +19.2% | 917 | 0.0% | 0.02% | +8.7% |
| Q3 2020 | $43,512,000 | -19.5% | 917 | 0.0% | 0.02% | -25.8% |
| Q2 2020 | $54,066,000 | +125634.9% | 917 | 0.0% | 0.03% | +6.9% |
| Q1 2020 | $43,000 | -21.8% | 917 | 0.0% | 0.03% | 0.0% |
| Q4 2019 | $55,000 | 0.0% | 917 | 0.0% | 0.03% | -12.1% |
| Q3 2019 | $55,000 | +816.7% | 917 | +817.0% | 0.03% | +725.0% |
| Q2 2019 | $6,000 | -25.0% | 100 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $8,000 | +60.0% | 100 | 0.0% | 0.01% | +25.0% |
| Q4 2018 | $5,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |